¥1,917.50
1.21% today
Tokyo, Nov 07, 07:14 am CET
ISIN
JP3197600004
Symbol
4528

Ono Pharmaceutical Stock price

¥1,928.50
+179.00 10.23% 1M
+358.50 22.83% 6M
+294.00 17.99% YTD
-75.50 3.77% 1Y
-1,549.50 44.55% 3Y
-1,292.50 40.13% 5Y
-1,450.50 42.93% 10Y
+884.56 84.73% 20Y
Tokyo, Closing price Fri, Nov 07 2025
-12.50 0.64%
ISIN
JP3197600004
Symbol
4528
Industry

New AI Insights on Ono Pharmaceutical Insights AI Insights on Ono Pharmaceutical

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
¥896.8b
Enterprise Value
¥844.3b
Net debt
positive
Cash
¥182.9b
Shares outstanding
469.9m
Valuation (TTM | estimate)
P/E
18.8 | 13.2
P/S
1.8 | 1.8
EV/Sales
1.7 | 1.7
EV/FCF
17.2
P/B
1.1
Dividends
DPS
¥80.00
Yield 1Y | 5Y
4.1% | 2.9%
Growth 1Y | 5Y
0.0% | 9.9%
Payout 1Y | 3Y
75.1% | 38.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥503.7b | ¥500.5b
EBITDA
¥92.4b | ¥124.8b
EBIT
¥55.9b | ¥111.1b
Net Income
¥48.5b | ¥68.9b
Free Cash Flow
¥49.1b
Growth (TTM | estimate)
Revenue
4.0% | 2.8%
EBITDA
-32.5% | 92.3%
EBIT
-52.9% | 80.8%
Net Income
-49.0% | 37.7%
Free Cash Flow
-46.6%
Margin (TTM | estimate)
Gross
67.6%
EBITDA
18.3% | 24.9%
EBIT
11.1%
Net
9.6% | 13.8%
Free Cash Flow
9.7%
Financial Health
Equity Ratio
73.5%
Return on Equity
6.4%
ROCE
6.1%
ROIC
6.2%
Debt/Equity
0.2
More
EPS
¥103.1
FCF per Share
¥104.4
Short interest
-
Employees
4k
Rev per Employee
¥126.4m
Show more

Is Ono Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Ono Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Ono Pharmaceutical forecast:

9x Hold
50%
9x Sell
50%

Analyst Opinions

18 Analysts have issued a Ono Pharmaceutical forecast:

Hold
50%
Sell
50%

Financial data from Ono Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
503,668 503,668
4% 4%
100%
- Direct Costs 163,049 163,049
37% 37%
32%
340,619 340,619
7% 7%
68%
- Selling and Administrative Expenses 128,418 128,418
16% 16%
25%
- Research and Development Expense 152,084 152,084
16% 16%
30%
92,384 92,384
32% 32%
18%
- Depreciation and Amortization 36,449 36,449
102% 102%
7%
EBIT (Operating Income) EBIT 55,935 55,935
53% 53%
11%
Net Profit 48,495 48,495
49% 49%
10%

In millions JPY.

Don't miss a Thing! We will send you all news about Ono Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Head office Japan
CEO Gyo Sagara
Employees 3,853
Founded 1947
Website www.ono-pharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today